Amneal Pharmaceuticals, Inc. AMRX AvKARE — Intellectual property legal development expenses

Other segment segments

Affordable Medicines

$1.32M-30.8%

Specialty

$49K-9.3%

Similar metrics at other companies

IONSPatent Expenses

$1.6M+20.8%

INSMARIKAYCE external R&D expenses — R&D

$8.62M-28.9%

IDCCResearch and portfolio development

$55.84M+17.7%

INSMARIKAYCE external R&D expenses — Product revenues, net

$98.11M+5.7%

TTEKLegal Fees

$0—

GKOSDevelopment And Commercialization Of Ophthalmic Therapies — Cost Of Impairment Of Intangible Assets

$28.22M—

Other financials

Income statement

See full

Revenue$722.5M+3.9%

Gross profit$320.1M+25.1%

Operating income$141.8M+41.3%

Net income$62.3M+411%

EPS (diluted)$0.19+375%

Balance sheet

See full

Cash & equivalents$197.7M+234%

Total debt$2.6B+17.7%

Total equity-$45.4M+65.5%

Total assets$3.5B+5.2%

Cash flow

See full

Operating cash flow-$26.7M-461%

CapEx$8.2M-37.9%

Free cash flow-$34.9M-507%

Valuation

See full

Market cap$5.17B+51.0%

Enterprise value$7.55B+33.4%

P/E42.4×—

P/S1.7×+0.5×

Profitability

See full

Gross margin38.7%+2.0pp

Operating margin14.3%+1.6pp

Net margin4%+3.6pp

FCF margin7.9%-1.0pp

Returns & leverage

See full

Return on equity-52.8%-12.7pp

Debt / equity127.9×+119×

Current ratio2.5×+1.1×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept amrx:IntellectualPropertyLegalDevelopmentExpenses.

The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amneal Pharmaceuticals, Inc.'s avkare — intellectual property legal development expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s avkare — intellectual property legal development expenses?: Amneal Pharmaceuticals, Inc. (AMRX) reported avkare — intellectual property legal development expenses of $0 in Q1 2026.
What does avkare — intellectual property legal development expenses mean?: Reflects costs associated with protecting, maintaining, and defending the intellectual property rights of the AvKARE segment's product portfolio. These expenses are critical for sustaining competitive advantages and preventing market entry by generic or biosimilar competitors.